Skip to main content

Umbrella menu

  • SfN.org
  • eNeuro
  • The Journal of Neuroscience
  • Neuronline
  • BrainFacts.org

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
  • ALERTS
  • FOR AUTHORS
    • Preparing a Manuscript
    • Submission Guidelines
    • Fees
    • Journal Club
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
  • SfN.org
  • eNeuro
  • The Journal of Neuroscience
  • Neuronline
  • BrainFacts.org

User menu

  • Log out
  • Log in
  • Subscribe
  • My alerts

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • Subscribe
  • My alerts
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
  • ALERTS
  • FOR AUTHORS
    • Preparing a Manuscript
    • Submission Guidelines
    • Fees
    • Journal Club
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
BRIEF COMMUNICATION

Reversible Memory Loss in a Mouse Transgenic Model of Alzheimer's Disease

Linda A. Kotilinek, Brian Bacskai, Marcus Westerman, Takeshi Kawarabayashi, Linda Younkin, Bradley T. Hyman, Steven Younkin and Karen H. Ashe
Journal of Neuroscience 1 August 2002, 22 (15) 6331-6335; DOI: https://doi.org/10.1523/JNEUROSCI.22-15-06331.2002
Linda A. Kotilinek
1Departments of Neurology and Neuroscience, University of Minnesota, Minneapolis 55455,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Bacskai
2Department of Neurology, Massachusetts General Hospital East, Charlestown, Massachusetts 02129, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus Westerman
1Departments of Neurology and Neuroscience, University of Minnesota, Minneapolis 55455,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takeshi Kawarabayashi
3Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Younkin
3Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradley T. Hyman
2Department of Neurology, Massachusetts General Hospital East, Charlestown, Massachusetts 02129, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Younkin
3Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen H. Ashe
1Departments of Neurology and Neuroscience, University of Minnesota, Minneapolis 55455,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Longitudinal experimental design using Tg2576 mice to determine whether memory loss, once present, can be restored. Spatial reference memory was measured, using the Morris water maze (Morris, 1984), immediately before and after intraperitoneal administration of BAM-10, a monoclonal antibody recognizing the N terminus of Aβ.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Spatial reference learning and memory in 9- to 11-month-old Tg2576 mice before and after treatment with BAM-10 antibody. The change in retention of spatial memory occurring as a result of receiving BAM-10 or IgG antibodies intraperitoneally was measured by subtracting baseline scores from post-treatment scores to obtain the change in percentage of time spent in the target quadrant (Change in %-time).a, Mice 9–11 months of age receiving BAM-10 antibody showed significantly greater improvement than mice receiving nonspecific IgG (*p = 0.03 by ttest; IgG, n = 17; BAM-10, n = 16). b, In mice that were impaired at baseline (<40% of the time spent in the target quadrant), those receiving BAM-10 antibody also showed significantly greater improvement than those receiving nonspecific IgG (*p = 0.04 by two-way ANOVA with repeated measures; IgG, n = 13; BAM-10,n = 14). Post-treatment performance of impaired mice receiving BAM-10 antibody was significantly higher than baseline performance (*p = 0.01 by paired ttest) and was similar to that of 2-month-old Tg2576 mice (n = 17) and 3-month-old nontransgenic littermates (n = 10). c, BAM-10, but not nonspecific IgG, restored the retention learning curve of 9- to 11-month-old Tg2576 mice to resemble that of 2-month-old (Young) Tg2576 mice. d, Acquisition of spatial reference memory improved in impaired mice receiving BAM-10 antibody, with significantly reduced mean escape latencies on days 3–5 (*p = 0.04 by paired t test), but not in mice receiving nonspecific IgG. There was a significant treatment-by-training session (baseline vs post-treatment) interaction (p = 0.03 by two-way ANOVA with repeated measures).

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Aβ levels in Tg2576 mice treated with BAM-10 or nonspecific IgG antibody. Total Aβ is the sum of Aβ40 and Aβ42 in TBS, 2% SDS, and formic acid (FA) soluble fractions measured as described previously (Kawarabayashi et al., 2001). a, Treatment of mice with BAM-10 was not associated with a significant reduction in total Aβ or in Aβ40 or Aβ42 in any of the fractions analyzed (p values ranged from 0.2 to 0.9). Measurements represent means ± SDs. Brain Aβ levels were correlated with memory in 8.7-month-old Tg2576 mice treated with BAM-10 or nonspecific IgG antibody. b, There was a significant inverse correlation between total Aβ and probe scores in control mice treated with nonspecific IgG.c, Treatment with BAM-10 eliminated the correlation between total Aβ and probe scores.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    BAM-10 neutralizes the cognitively disruptive activity of small Aβ assemblies in the brain. Top, Memory loss in Tg2576 mice appears to be caused by small Aβ assemblies (stars) (Westerman et al., 2002) formed during the conversion of Aβ monomers (circles) to amyloid deposits (starbursts). Aging refers to the event or series of events occurring as animals age leading to the initial aggregation of monomeric Aβ. Little is known about what comprises these events. Bottom, BAM-10 penetrates into the brain, where it may bind to these small Aβ assemblies, neutralize their deleterious effects on cognitive function, and rapidly restore memory in Tg2576 mice. With prolonged treatment, a reduction in amyloid deposits may occur.

Back to top

In this issue

The Journal of Neuroscience: 22 (15)
Journal of Neuroscience
Vol. 22, Issue 15
1 Aug 2002
  • Table of Contents
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Reversible Memory Loss in a Mouse Transgenic Model of Alzheimer's Disease
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Reversible Memory Loss in a Mouse Transgenic Model of Alzheimer's Disease
Linda A. Kotilinek, Brian Bacskai, Marcus Westerman, Takeshi Kawarabayashi, Linda Younkin, Bradley T. Hyman, Steven Younkin, Karen H. Ashe
Journal of Neuroscience 1 August 2002, 22 (15) 6331-6335; DOI: 10.1523/JNEUROSCI.22-15-06331.2002

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Reversible Memory Loss in a Mouse Transgenic Model of Alzheimer's Disease
Linda A. Kotilinek, Brian Bacskai, Marcus Westerman, Takeshi Kawarabayashi, Linda Younkin, Bradley T. Hyman, Steven Younkin, Karen H. Ashe
Journal of Neuroscience 1 August 2002, 22 (15) 6331-6335; DOI: 10.1523/JNEUROSCI.22-15-06331.2002
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • Alzheimer's disease
  • transgenic
  • behavior
  • Aβ
  • monoclonal antibodies
  • memory

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • Inter-regional Contribution of Enhanced Activity of the Primary Somatosensory Cortex to the Anterior Cingulate Cortex Accelerates Chronic Pain Behavior
  • MrgD Activation Inhibits KCNQ/M-Currents and Contributes to Enhanced Neuronal Excitability
  • Dopaminergic Substantia Nigra Neurons Project Topographically Organized to the Subventricular Zone and Stimulate Precursor Cell Proliferation in Aged Primates
Show more Brief Communication
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(JNeurosci logo)
(SfN logo)

Copyright © 2021 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.